E. P. Marinos serves as Executive at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/, where they oversee executive responsibilities. Since joining the company, E. P. Marinos has executed 8 insider transactions totaling $6.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 15, 2017 involved receiving (via award) 720 shares valued at $2.6K.
E. P. Marinos currently holds 68,183 shares of ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, E. P. Marinos has been a net buyer of HRT stock. They have purchased $6.2K and sold $0 worth of shares.
E. P. Marinos's most recent insider trade was on Nov 15, 2017, when they sold 720 shares at $3.68 per share.
Get notified when new Form 4 filings are submitted
| $3.98 |
| Discretionary |
| Sep 29, 2017 | MICR | $3.8K | Award | 987 | $3.80 | Discretionary |
| Jan 4, 2016 | HRT | $25.6K | Option Exercise | 7,500 | $3.41 | Discretionary |
| Dec 2, 2013 | HRT | $0 | Award | 6,000 | $N/A | Discretionary |
| Dec 10, 2008 | HRT | $1.2K | Purchase | 500 | $2.43 | Discretionary |
| Dec 10, 2008 | HRT | $1.2K | Purchase | 500 | $2.48 | Discretionary |
| Dec 10, 2008 | HRT | $3.8K | Purchase | 1,500 | $2.50 | Discretionary |